Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Coherus Oncology, Inc.
Coherus Oncology, Inc.
Bayer
Intensity Therapeutics, Inc.
Celldex Therapeutics
Bayer
Xencor, Inc.
National Institutes of Health Clinical Center (CC)